Home6C1 • FRA
add
CytomX Therapeutics Inc
Previous close
€2.88
Day range
€2.74 - €2.74
Year range
€0.38 - €2.98
Market cap
527.72M USD
Avg Volume
445.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 18.66M | -25.71% |
Operating expense | 19.94M | -40.58% |
Net income | -154.00K | 97.64% |
Net profit margin | -0.83 | 96.81% |
Earnings per share | 0.00 | 100.00% |
EBITDA | -939.00K | 88.25% |
Effective tax rate | -69.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 158.09M | 15.24% |
Total assets | 175.06M | 9.95% |
Total liabilities | 55.15M | -71.04% |
Total equity | 119.91M | — |
Shares outstanding | 164.91M | — |
Price to book | 3.94 | — |
Return on assets | -2.35% | — |
Return on capital | -4.02% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -154.00K | 97.64% |
Cash from operations | -15.75M | 19.42% |
Cash from investing | -76.36M | -454.96% |
Cash from financing | 93.55M | 1,734.67% |
Net change in cash | 1.44M | -79.65% |
Free cash flow | -9.97M | -260.53% |
About
Founded
2008
Headquarters
Website
Employees
120
